Phosphatidylinositol 3-kinase (PI3K) Alpha iNhibition In Advanced Breast Cancer
Clinical trial NCT02506556 · COMPLETED
Trial details
- NCT number
- NCT02506556
- Sponsor
- Peter MacCallum Cancer Centre, Australia
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-07
- Primary completion
- 2021-10-26
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.